CDC’s ACIP recommends Shingrix for immunocompromised adults aged 19+
by Press Release from Outbreak News Today on (#5R03H)
By NewsDesk @bactiman63 GlaxoSmithKline announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend two doses of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) and its complications in adults 19 years of age and older who are or will be immunodeficient [...]
The post CDC's ACIP recommends Shingrix for immunocompromised adults aged 19+ appeared first on Outbreak News Today.